Cargando…

A patient decision aid for risk‐reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing

BACKGROUND: BRCA1/2 mutation carriers’ choice between risk‐reducing salpingo‐oophorectomy (RRSO) and salpingectomy with delayed oophorectomy is very complex. Aim was to develop a patient decision aid that combines evidence with patient preferences to facilitate decision making. DESIGN: Systematic de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harmsen, Marline G., Steenbeek, Miranda P., Hoogerbrugge, Nicoline, van Doorn, Helena C., Gaarenstroom, Katja N., Vos, M. Caroline, Massuger, Leon F.A.G., de Hullu, Joanne A., Hermens, Rosella P.M.G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980589/ https://www.ncbi.nlm.nih.gov/pubmed/29281161 http://dx.doi.org/10.1111/hex.12661

Ejemplares similares

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study
por: Harmsen, Marline G., et al.
Publicado: (2015)

Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors
por: van Bommel, Majke H. D., et al.
Publicado: (2022)

Factors influencing decision-making around opportunistic salpingectomy: a nationwide survey
por: Steenbeek, Miranda P., et al.
Publicado: (2018)

Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis
por: van Bommel, Majke H D, et al.
Publicado: (2022)

Finding all BRCA pathogenic mutation carriers: best practice models
por: Hoogerbrugge, Nicoline, et al.
Publicado: (2016)

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
por: Zaaijer, Leendert H, et al.
Publicado: (2016)

No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study
por: Hermsen, B B J, et al.
Publicado: (2007)

Adequacy of family history taking in ovarian cancer patients: a population-based study
por: van Altena, Anne M., et al.
Publicado: (2012)

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI
por: Veltman, J., et al.
Publicado: (2008)

Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome
por: Gerritzen, Lotte H. M., et al.
Publicado: (2009)

Collaboration Benefits All
por: Hemida, Reda A., et al.
Publicado: (2020)

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors
por: Stroot, Iris A.S., et al.
Publicado: (2023)

Improving calculation, interpretation and communication of familial colorectal cancer risk: Protocol for a randomized controlled trial
por: Dekker, Nicky, et al.
Publicado: (2010)

Lifestyle Risk Factors for Breast Cancer in BRCA1/2-Mutation Carriers Around Childbearing Age
por: van Erkelens, A., et al.
Publicado: (2016)

Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas
por: Weren, Robbert D.A., et al.
Publicado: (2016)

Sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma: a proposed protocol for a multicentre observational study
por: van Doorn, Helena C., et al.
Publicado: (2022)

Patient involvement via videoconference at the morbidity and mortality (M&M) meeting during COVID-19
por: Myren, Britt Jose, et al.
Publicado: (2022)

A comprehensive eHealth implementation guide constructed on a qualitative case study on barriers and facilitators of the digital care platform CMyLife
por: Verweij, Lynn, et al.
Publicado: (2022)

Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study
por: Gaba, Faiza, et al.
Publicado: (2022)

Healthcare professionals’ perspectives of barriers and facilitators in implementing physical activity programmes delivered to cancer survivors in a shared-care model: a qualitative study
por: IJsbrandy, Charlotte, et al.
Publicado: (2019)

Patients’ and professionals’ perspectives on implementation of opportunistic salpingectomy: a mixed-method study
por: Gelderblom, Malou E., et al.
Publicado: (2021)

Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial
por: Visser, Annemiek, et al.
Publicado: (2011)

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition
por: Vos, Janet R, et al.
Publicado: (2019)

Surveillance of women at high risk for hereditary ovarian cancer is inefficient
por: Oei, A L, et al.
Publicado: (2006)

Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening?
por: Oei, A L M, et al.
Publicado: (2006)

Implementation of the three good questions—A feasibility study in Dutch hospital departments
por: Garvelink, Mirjam M., et al.
Publicado: (2019)

Most Patients with Colorectal Tumors at Young Age Do Not Visit a Cancer Genetics Clinic
por: Overbeek, Lucia I. H., et al.
Publicado: (2008)

Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
por: McKinley, Joanne M, et al.
Publicado: (2007)

TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol
por: Steenbeek, Miranda P, et al.
Publicado: (2023)

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2012)

Determinants of adherence to recommendations for cancer prevention among Lynch Syndrome mutation carriers: A qualitative exploration
por: Visser, Annemiek, et al.
Publicado: (2017)

Improving patient-centeredness of fertility care using a multifaceted approach: study protocol for a randomized controlled trial
por: Huppelschoten, Aleida G, et al.
Publicado: (2012)

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
por: Iqbal, J, et al.
Publicado: (2012)

Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes
por: Vos, Janet R., et al.
Publicado: (2018)

Hormone Replacement Therapy Appears to Be Safe After Prophylactic Adnexectomy in Premenopausal BRCA1/BRCA2 Mutation Carriers. Reaction to the 'Letter to readers' in Hereditary Cancer in Clinical Practice, 2005, 3 (2)
por: Lubiński, Jan
Publicado: (2005)

Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Odén, Lovisa, et al.
Publicado: (2016)

A Systematic Review and Multilevel Regression Analysis Reveals the Comorbidity Prevalence in Cancer
por: Vrinzen, Cilla E.J., et al.
Publicado: (2023)

Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
por: Krassuski, Lisa, et al.
Publicado: (2019)

Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction
por: Tai, Yu Chuan, et al.
Publicado: (2008)

Decision aids for female BRCA mutation carriers: a scoping review protocol
por: McGarrigle, Sarah A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4frnk6m0hcb21m73hdgjsvdbfb